| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |